Laina Mercer

9PUBLICATIONS
35CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infant and child healthNanotoxicology, health and safetyMajor global burdens of diseaseAgricultural molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 26, 2026
Safety and Immunogenicity of an Additional Dose of Thailand Government Pharmaceutical Organization (GPO) Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Administered After Primary Vaccination with HXP-GPOVac or BNT162b2: An Open-Label Phase II Extension Trial in Thai Adults.

|Jul 22, 2026
Persistence of Serum Bactericidal Antibody in the First 2-Years After Immunization with Pentavalent Meningococcal ACWYX Vaccine in Malian Infants and Toddlers.

|Jun 25, 2026
Safety and Immunogenicity of a Locally Produced Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Compared with BNT162b2: A Phase II Randomized, Controlled, Double-Blind Noninferiority Trial in Thai Adults.

|Feb 12, 2022
Evaluating stability of attenuated Sabin and two novel type 2 oral poliovirus vaccines in children.

Rahnuma Wahid, Laina Mercer, Chris Gast

|Nov 18, 2021
A Phase 2a randomized, single-center, double-blind, placebo-controlled study to evaluate the safety and preliminary efficacy of oral iOWH032 against cholera diarrhea in a controlled human infection model.

Rahsan Erdem, Gwen Ambler, Mohamed Al-Ibrahim

|Jul 30, 2021
Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses.

Rahnuma Wahid, Laina Mercer, Andrew Macadam

Pageof 2

Frequent Collaborators

2 joint publications

Somchaiya Surichan

2 joint publications

Rahnuma Wahid

2 joint publications

Christina S Polyak

2 joint publications

Konstantin Chumakov